Drugs Online » Prescription Drugs 11 » Nicardia Retard SR Adalat
Nifedipine is used to treat high blood pressure. It relaxes your blood vessels so your heart does not have to pump as hard. It also increases the supply of blood and oxygen to the heart to control chest pain (angina). If taken regularly nifedipine controls chest pain but it does not stop chest pain once it starts.
Buy Nicardia Retard SR Adalat and other Prescription Drugs 11 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Nicardia Retard SR Adalat:
Product Type: Prescription Drugs 11
Nicardia Retard SR (Adalat Procardia Nifedecal Generic Nifedipine)
Nicardia Retard SR (Adalat Procardia Nifedecal Generic Nifedipine)
Adalat Procardia Nifedecal Generic Nifedipine
10mg 100 Tablets 10mg 400(2 x 200) Tablets 10mg 800(4 x 200) Tablets 20mg 200 Tablets 20mg 400(2 x 200) Tablets 20mg 800(4 x 200) Tablets
Adalat Procardia Nifedecal Generic Nifedipine Nicardia Retard SR

View more
Prescription Drugs 11
Previous Product Next Product
Drugs Online:
From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.


|